127 related articles for article (PubMed ID: 14552430)
1. Update in the pathologic features of mature B-cell and T/NK-cell leukemias.
Hsi ED; Mirza I
Semin Diagn Pathol; 2003 Aug; 20(3):180-95. PubMed ID: 14552430
[TBL] [Abstract][Full Text] [Related]
2. The leukemias of mature lymphocytes.
Hsi ED
Hematol Oncol Clin North Am; 2009 Aug; 23(4):843-71. PubMed ID: 19577172
[TBL] [Abstract][Full Text] [Related]
3. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
[TBL] [Abstract][Full Text] [Related]
4. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
Suzuki R; Nakamura S
Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotyping of mature T/NK cell neoplasm presenting as leukemia.
Gujral S; Polampalli S; Badrinath Y; Kumar A; Subramanian PG; Nair R; Sengar M; Nair C
Indian J Cancer; 2010; 47(2):189-93. PubMed ID: 20448385
[TBL] [Abstract][Full Text] [Related]
7. CD56+ hematologic malignancies.
Loughran TP
Leuk Res; 1999 Jul; 23(7):675-6. PubMed ID: 10400189
[No Abstract] [Full Text] [Related]
8. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.
DiGiuseppe JA; Louie DC; Williams JE; Miller DT; Griffin CA; Mann RB; Borowitz MJ
Am J Surg Pathol; 1997 Oct; 21(10):1223-30. PubMed ID: 9331296
[TBL] [Abstract][Full Text] [Related]
9. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation.
Yagita M; Huang CL; Umehara H; Matsuo Y; Tabata R; Miyake M; Konaka Y; Takatsuki K
Leukemia; 2000 May; 14(5):922-30. PubMed ID: 10803526
[TBL] [Abstract][Full Text] [Related]
10. Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma.
Matsuo Y; Drexler HG
Leuk Res; 2003 Oct; 27(10):935-45. PubMed ID: 12860014
[TBL] [Abstract][Full Text] [Related]
11. Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity.
Sun T; Brody J; Susin M; Marino J; Teichberg S; Koduru P; Hall WW; Urmacher C; Hajdu SI
Am J Surg Pathol; 1993 Dec; 17(12):1289-99. PubMed ID: 8238737
[TBL] [Abstract][Full Text] [Related]
12. Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations.
Siu LL; Wong KF; Chan JK; Kwong YL
Am J Pathol; 1999 Nov; 155(5):1419-25. PubMed ID: 10550295
[TBL] [Abstract][Full Text] [Related]
13. Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma.
Drexler HG; Matsuo Y
Leukemia; 2000 May; 14(5):777-82. PubMed ID: 10803505
[TBL] [Abstract][Full Text] [Related]
14. Pathology of chronic lymphocytic leukemia: an update.
Inamdar KV; Bueso-Ramos CE
Ann Diagn Pathol; 2007 Oct; 11(5):363-89. PubMed ID: 17870025
[TBL] [Abstract][Full Text] [Related]
15. CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity?
Sheikh SS; Kallakury BV; Al-Kuraya KA; Meck J; Hartmann DP; Bagg A
Am J Hematol; 2002 Dec; 71(4):306-10. PubMed ID: 12447961
[TBL] [Abstract][Full Text] [Related]
16. Differential roles of miR-15a/16-1 and miR-497/195 clusters in immune cell development and homeostasis.
Hutter K; Rülicke T; Drach M; Andersen L; Villunger A; Herzog S
FEBS J; 2021 Mar; 288(5):1533-1545. PubMed ID: 32705746
[TBL] [Abstract][Full Text] [Related]
17. Association of B-chronic lymphocytic leukaemia and T-large granular lymphocyte leukaemia.
Lesesve JF; Feugier P; Lamy T; Béné MC; Grégoire MJ; Lenormand B; Loughran T
Clin Lab Haematol; 2000 Apr; 22(2):121-2. PubMed ID: 10792405
[No Abstract] [Full Text] [Related]
18. Chronic lymphoid leukemias other than chronic lymphocytic leukemia: diagnosis and treatment.
Ravandi F; O'Brien S
Mayo Clin Proc; 2005 Dec; 80(12):1660-74. PubMed ID: 16342661
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
20. Aberrant NK cell associated marker (CD56 and CD57) expression in chronic lymphocytic leukemia.
Dorwal P; Mehra S; Pande A; Jain D; Smeeta G; Sachdev R; Raina V
Cytometry B Clin Cytom; 2015; 88(5):348-51. PubMed ID: 26013700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
